X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (198) 198
dermatology (166) 166
pimecrolimus cream 1-percent (142) 142
index medicus (140) 140
double-blind (112) 112
atopic dermatitis (103) 103
pimecrolimus (85) 85
dermatitis, atopic - drug therapy (75) 75
calcineurin inhibitors (73) 73
tacrolimus ointment (73) 73
tacrolimus - analogs & derivatives (70) 70
tacrolimus (69) 69
male (56) 56
tacrolimus - therapeutic use (56) 56
efficacy (54) 54
child (51) 51
female (51) 51
long-term management (51) 51
treatment outcome (51) 51
administration, topical (50) 50
children (50) 50
atopic-dermatitis (47) 47
topical calcineurin inhibitors (47) 47
dermatologic agents - therapeutic use (46) 46
eczema (45) 45
safety (45) 45
adult (44) 44
dermatitis (44) 44
tacrolimus - administration & dosage (42) 42
skin (41) 41
administration, cutaneous (39) 39
immunosuppressive agents - therapeutic use (39) 39
1-percent (33) 33
quality-of-life (32) 32
corticosteroids (30) 30
cream 1-percent (30) 30
severity of illness index (30) 30
medicine & public health (29) 29
adrenal cortex hormones - therapeutic use (28) 28
care and treatment (28) 28
tacrolimus - adverse effects (28) 28
drug therapy (27) 27
quality of life (27) 27
child, preschool (26) 26
adult patients (25) 25
allergy (25) 25
dermatitis, atopic - therapy (25) 25
pharmacology & pharmacy (25) 25
skin diseases (25) 25
adolescent (24) 24
animals (24) 24
immunosuppressive agents - administration & dosage (24) 24
middle aged (24) 24
pediatric-patients (24) 24
randomized controlled-trial (24) 24
dermatologic agents - administration & dosage (23) 23
randomized controlled trials as topic (23) 23
infants (22) 22
pimecrolimus 1-percent cream (22) 22
sdz asm 981 (22) 22
health aspects (21) 21
pharmacology/toxicology (21) 21
pharmacotherapy (21) 21
therapy (21) 21
immunology (20) 20
clinical trials (19) 19
placebo-controlled trial (19) 19
antiinflammatory drug (18) 18
pediatrics (18) 18
risk factors (18) 18
controlled-trial (17) 17
dermatologic agents - adverse effects (17) 17
management (17) 17
psoriasis (17) 17
topical corticosteroids (17) 17
1-percent pimecrolimus cream (16) 16
analysis (16) 16
diagnosis (16) 16
evidence-based medicine (16) 16
ointments (16) 16
seborrheic dermatitis (16) 16
aged (15) 15
clinical trials as topic (15) 15
dermatitis, atopic - diagnosis (15) 15
hydrocortisone acetate (15) 15
immunosuppressive agents - adverse effects (15) 15
lichen planus (15) 15
0.1-percent tacrolimus ointment (14) 14
adrenal cortex hormones - administration & dosage (14) 14
calcineurin inhibitors - therapeutic use (14) 14
dermatitis, seborrheic - drug therapy (14) 14
diagnosis, differential (14) 14
inflammation (14) 14
medicine, general & internal (14) 14
calcineurin (13) 13
clinical-trial (13) 13
lichen planus, oral - drug therapy (13) 13
phototherapy (13) 13
skin diseases - drug therapy (13) 13
young adult (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 08/2012, Volume 26, Issue 8, pp. 1045 - 1060
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 131, Issue 2, pp. 295 - 299.e27
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 08/2013, Volume 14, Issue 4, pp. 279 - 290
Granuloma annulare (GA) is a common cutaneous disorder classically presenting as annular groups of skin-colored to erythematous papules without epidermal... 
PHOTODYNAMIC THERAPY | EFFICACY | ISOTRETINOIN | PIMECROLIMUS 1-PERCENT CREAM | ULTRAVIOLET | INFECTION | PATIENT | TNF-ALPHA | TACROLIMUS | RECALCITRANT | DERMATOLOGY
Journal Article
by Wollenberg, A and Barbarot, S and Bieber, T and Christen‐Zaech, S and Deleuran, M and Fink‐Wagner, A and Gieler, U and Girolomoni, G and Lau, S and Muraro, A and Czarnecka‐Operacz, M and Schäfer, T and Schmid‐Grendelmeier, P and Simon, D and Szalai, Z and Szepietowski, J.C and Taïeb, A and Torrelo, A and Werfel, T and Ring, J and EAACI and European Federation Allergy Airway and European Soc Dermatology Psychiat and EDF and Global Allergy Asthma European Net and ESPD and UEMS and EADV and ETFAD and European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS) and the European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 05/2018, Volume 32, Issue 5, pp. 657 - 682
Journal Article